Benjamin J. Hindson, See Remarks at 10x Genomics, Inc. (TXG), sold 27,880 shares at $60.03 ($1.7M) on 2023-07-19, disclosed to the SEC on 2023-07-21.
Scheduled sale ($1.7M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.03 | 13,940 | $837K | 50.0% |
| 2 | $60.03 | 13,940 | $837K | 50.0% |
| Total | $60.03 avg | 27,880 | $1.7M | 100% |
| Filing → |
| TXG | SELL | 2026-02-25 | $145K | — | Filing → |
| TXG | SELL | 2025-11-25 | $157K | — | Filing → |
| TXG | SELL | 2025-08-26 | $206K | — | Filing → |